Patent US4158057A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4158057A Expired / Lapsed US ⏱️ 0.0 years remaining

Prevention of the accumulation of fatty deposits in the liver

Assignee: Individual
•
Filing: 1975-03-28
•
Granted: 1979-06-12
•
Expires: 1995-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is provided for preventing the accumulation of fatty deposits in mammalian livers due to ingestion of alcohol. The method consists of administering a suitable dosage of a mixture of pyruvate and dihydroxyacetone to which riboflavin may also be added.

Inventors

  • 👤 Ronald T. Stanko

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 22:47
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61K31/519; A61K31/525; A61K31/185; A61K31/19

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 37 words
A method of preventing excessive accumulation of fatty deposits in the liver of a mammal due to ingestion of ethanol which comprises administering orally to said mammal a therapeutic mixture of effective amounts of pyruvate and dihydroxyacetone.
Claim 2
Independent Claim 37 words
A method of preventing excessive accumulation of fatty deposits in the liver of a mammal due to ingestion of ethanol which comprises administering orally to said mammal a therapeutic mixture of effective amounts of pyruvate and dihydroxyacetone.
Claim 3
Dependent Claim 12 words
The method of claim 1 in which said mixture also includes riboflavin.
Claim 4
Dependent Claim 17 words
The method of claim 1 in which said mixture contains substantially equal parts of pyruvate and dihydroxyacetone.
Claim 5
Dependent Claim 28 words
The method of claim 1 in which said mixture is administered in an amount of the order of eleven grams per liter of dietary intake of the mammal.
Claim 6
Dependent Claim 34 words
A therapeutic composition for oral administration for prevention of excessive accumulation of fatty deposits in mammalian livers due to ingestion of ethanol, said composition comprising a mixture of effective amounts of pyruvate and dihydroxyacetone.
Claim 7
Dependent Claim 34 words
A therapeutic composition for oral administration for prevention of excessive accumulation of fatty deposits in mammalian livers due to ingestion of ethanol, said composition comprising a mixture of effective amounts of pyruvate and dihydroxyacetone.
Claim 8
Dependent Claim 11 words
The composition of claim 5 including riboflavin as an additional constituent.
Claim 9
Dependent Claim 17 words
The composition of claim 5 in which the pyruvate and dihydroxyacetone are present in substantially equal parts.
Claim 10
Dependent Claim 12 words
The composition of claim 7 and including riboflavin as an additional constituent.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-06-11 1982-12-11 1983-06-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-06-11 1986-12-11 1987-06-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-06-11 1990-12-11 1991-06-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag